Vaccines Market Size, Share & Trends Analysis Report By Type (Monovalent, Multivalent), By Route of Administration (Oral, Parenteral, Nasal), By Disease Indication (Viral, Bacterial), By Age Group (Pediatric, Adult) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: September 11, 2026 | Author: Dhanashri B | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Vaccines Market Size Analysis
    1. Introduction
    2. Vaccines Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monovalent
      2. Multivalent
    3. Vaccines Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
      3. Nasal
    4. Vaccines Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Viral
        1. Hepatitis Vaccine
        2. Influenza Vaccine
        3. Human Papillomavirus (HPV) Vaccine
        4. Rotavirus Vaccine (RV)
        5. Polio Vaccine
        6. Varicella Vaccine
        7. COVID-19 Vaccine
        8. Measles, Mumps and Rubella (MMR) Vaccine
        9. Other Vaccines
      2. Bacterial
        1. Pneumococcal Conjugate Vaccine (PCV)
        2. Meningococcal Vaccine
        3. Diphtheria, Tetanus, and Pertussis Vaccines
        4. Other Vaccines
    5. Vaccines Market Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
      1. Pediatric
      2. Adult
  7. North America Vaccines Market Size Analysis
    1. Introduction
    2. Vaccines Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monovalent
      2. Multivalent
    3. Vaccines Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
      3. Nasal
    4. Vaccines Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Viral
        1. Hepatitis Vaccine
        2. Influenza Vaccine
        3. Human Papillomavirus (HPV) Vaccine
        4. Rotavirus Vaccine (RV)
        5. Polio Vaccine
        6. Varicella Vaccine
        7. COVID-19 Vaccine
        8. Measles, Mumps and Rubella (MMR) Vaccine
        9. Other Vaccines
      2. Bacterial
        1. Pneumococcal Conjugate Vaccine (PCV)
        2. Meningococcal Vaccine
        3. Diphtheria, Tetanus, and Pertussis Vaccines
        4. Other Vaccines
    5. Vaccines Market Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
      1. Pediatric
      2. Adult
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
  8. Europe Vaccines Market Size Analysis
    1. Introduction
    2. Vaccines Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monovalent
      2. Multivalent
    3. Vaccines Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
      3. Nasal
    4. Vaccines Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Viral
        1. Hepatitis Vaccine
        2. Influenza Vaccine
        3. Human Papillomavirus (HPV) Vaccine
        4. Rotavirus Vaccine (RV)
        5. Polio Vaccine
        6. Varicella Vaccine
        7. COVID-19 Vaccine
        8. Measles, Mumps and Rubella (MMR) Vaccine
        9. Other Vaccines
      2. Bacterial
        1. Pneumococcal Conjugate Vaccine (PCV)
        2. Meningococcal Vaccine
        3. Diphtheria, Tetanus, and Pertussis Vaccines
        4. Other Vaccines
    5. Vaccines Market Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
      1. Pediatric
      2. Adult
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    8. France
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
  9. APAC Vaccines Market Size Analysis
    1. Introduction
    2. Vaccines Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monovalent
      2. Multivalent
    3. Vaccines Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
      3. Nasal
    4. Vaccines Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Viral
        1. Hepatitis Vaccine
        2. Influenza Vaccine
        3. Human Papillomavirus (HPV) Vaccine
        4. Rotavirus Vaccine (RV)
        5. Polio Vaccine
        6. Varicella Vaccine
        7. COVID-19 Vaccine
        8. Measles, Mumps and Rubella (MMR) Vaccine
        9. Other Vaccines
      2. Bacterial
        1. Pneumococcal Conjugate Vaccine (PCV)
        2. Meningococcal Vaccine
        3. Diphtheria, Tetanus, and Pertussis Vaccines
        4. Other Vaccines
    5. Vaccines Market Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
      1. Pediatric
      2. Adult
    6. China
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    9. India
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
  10. Middle East and Africa Vaccines Market Size Analysis
    1. Introduction
    2. Vaccines Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monovalent
      2. Multivalent
    3. Vaccines Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
      3. Nasal
    4. Vaccines Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Viral
        1. Hepatitis Vaccine
        2. Influenza Vaccine
        3. Human Papillomavirus (HPV) Vaccine
        4. Rotavirus Vaccine (RV)
        5. Polio Vaccine
        6. Varicella Vaccine
        7. COVID-19 Vaccine
        8. Measles, Mumps and Rubella (MMR) Vaccine
        9. Other Vaccines
      2. Bacterial
        1. Pneumococcal Conjugate Vaccine (PCV)
        2. Meningococcal Vaccine
        3. Diphtheria, Tetanus, and Pertussis Vaccines
        4. Other Vaccines
    5. Vaccines Market Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
      1. Pediatric
      2. Adult
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
  11. LATAM Vaccines Market Size Analysis
    1. Introduction
    2. Vaccines Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monovalent
      2. Multivalent
    3. Vaccines Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
      3. Nasal
    4. Vaccines Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Viral
        1. Hepatitis Vaccine
        2. Influenza Vaccine
        3. Human Papillomavirus (HPV) Vaccine
        4. Rotavirus Vaccine (RV)
        5. Polio Vaccine
        6. Varicella Vaccine
        7. COVID-19 Vaccine
        8. Measles, Mumps and Rubella (MMR) Vaccine
        9. Other Vaccines
      2. Bacterial
        1. Pneumococcal Conjugate Vaccine (PCV)
        2. Meningococcal Vaccine
        3. Diphtheria, Tetanus, and Pertussis Vaccines
        4. Other Vaccines
    5. Vaccines Market Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
      1. Pediatric
      2. Adult
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
  12. Competitive Landscape
    1. Vaccines Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Pfizer Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Moderna, Inc.
    3. Merck & Co., Inc.
    4. GSK plc
    5. Sanofi
    6. BioNTech SE. 
    7. Johnson & Johnson
    8. China National Biotec Group Company Limited (CNBG)
    9. AstraZeneca
    10. Serum Institute of India (SII)
    11. Bejing
    12. CSL Behring
    13. Walvax Biotechnology Co., Ltd. 
    14. Bavarian Nordic Inc.
    15. Takeda Pharmaceutical Company Limited
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

List of Tables

Table 1: Global Vaccines Market Size and Forecast By Regions - 2022-2034 (USD Billion)

Table 2: Global Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 3: Global Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 4: Global Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 5: Global Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 6: North America Vaccines Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 7: North America Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 8: North America Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 9: North America Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 10: North America Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 11: U.S. Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 12: U.S. Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 13: U.S. Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 14: U.S. Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 15: Canada Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 16: Canada Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 17: Canada Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 18: Canada Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 19: Europe Vaccines Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 20: Europe Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 21: Europe Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 22: Europe Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 23: Europe Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 24: U.K. Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 25: U.K. Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 26: U.K. Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 27: U.K. Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 28: Germany Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 29: Germany Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 30: Germany Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 31: Germany Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 32: France Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 33: France Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 34: France Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 35: France Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 36: Spain Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 37: Spain Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 38: Spain Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 39: Spain Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 40: Italy Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 41: Italy Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 42: Italy Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 43: Italy Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 44: Russia Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 45: Russia Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 46: Russia Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 47: Russia Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 48: Nordic Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 49: Nordic Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 50: Nordic Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 51: Nordic Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 52: Benelux Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 53: Benelux Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 54: Benelux Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 55: Benelux Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 56: Rest of Europe Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 57: Rest of Europe Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 58: Rest of Europe Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 59: Rest of Europe Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 60: APAC Vaccines Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 61: APAC Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 62: APAC Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 63: APAC Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 64: APAC Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 65: China Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 66: China Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 67: China Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 68: China Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 69: Korea Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 70: Korea Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 71: Korea Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 72: Korea Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 73: Japan Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 74: Japan Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 75: Japan Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 76: Japan Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 77: India Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 78: India Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 79: India Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 80: India Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 81: Australia Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 82: Australia Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 83: Australia Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 84: Australia Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 85: Taiwan Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 86: Taiwan Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 87: Taiwan Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 88: Taiwan Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 89: South East Asia Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 90: South East Asia Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 91: South East Asia Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 92: South East Asia Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 93: Rest of Asia-Pacific Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 94: Rest of Asia-Pacific Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 95: Rest of Asia-Pacific Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 96: Rest of Asia-Pacific Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 97: Middle East and Africa Vaccines Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 98: Middle East and Africa Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 99: Middle East and Africa Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 100: Middle East and Africa Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 101: Middle East and Africa Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 102: UAE Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 103: UAE Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 104: UAE Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 105: UAE Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 106: Turkey Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 107: Turkey Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 108: Turkey Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 109: Turkey Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 110: Saudi Arabia Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 111: Saudi Arabia Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 112: Saudi Arabia Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 113: Saudi Arabia Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 114: South Africa Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 115: South Africa Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 116: South Africa Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 117: South Africa Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 118: Egypt Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 119: Egypt Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 120: Egypt Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 121: Egypt Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 122: Nigeria Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 123: Nigeria Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 124: Nigeria Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 125: Nigeria Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 126: Rest of MEA Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 127: Rest of MEA Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 128: Rest of MEA Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 129: Rest of MEA Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 130: LATAM Vaccines Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 131: LATAM Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 132: LATAM Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 133: LATAM Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 134: LATAM Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 135: Brazil Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 136: Brazil Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 137: Brazil Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 138: Brazil Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 139: Mexico Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 140: Mexico Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 141: Mexico Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 142: Mexico Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 143: Argentina Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 144: Argentina Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 145: Argentina Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 146: Argentina Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 147: Chile Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 148: Chile Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 149: Chile Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 150: Chile Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 151: Colombia Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 152: Colombia Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 153: Colombia Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 154: Colombia Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

Table 155: Rest of LATAM Vaccines Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 156: Rest of LATAM Vaccines Market Size and Forecast By Route of Administration - 2022-2034 (USD Billion)

Table 157: Rest of LATAM Vaccines Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 158: Rest of LATAM Vaccines Market Size and Forecast By Age Group - 2022-2034 (USD Billion)

We are featured on: